These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22648898)

  • 1. Reactive arthritis responding to antiretroviral therapy in an HIV-1-infected individual.
    Scott C; Brand A; Natha M
    Int J STD AIDS; 2012 May; 23(5):373-4. PubMed ID: 22648898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How individual can personalized antiretroviral treatment be? Deep salvage in an HIV-1-infected patient.
    Jensen B; Esser S; Kaiser R; Luebke N; Häussinger D
    Intervirology; 2012; 55(2):167-71. PubMed ID: 22286888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect and safety evaluation on 6-year highly active antiretroviral therapy for Chinese HIV-1 infected patients].
    Zhou H; Zheng Y; He Y; Gong G; Chen Z; Liu M; Yin W; Liu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):731-7. PubMed ID: 19734579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
    Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
    Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam.
    Huong DT; Bannister W; Phong PT; Kirk O; Peters L
    Int J STD AIDS; 2011 Nov; 22(11):659-64. PubMed ID: 22096052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
    Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
    J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy.
    Wegrzyn J; Livrozet JM; Touraine JL; Miossec P
    J Rheumatol; 2002 Oct; 29(10):2232-4. PubMed ID: 12375339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.
    Briz V; León-Leal JA; Palladino C; Moreno-Perez D; de Ory SJ; De José MI; González-Tomé MI; Martín CG; Pocheville I; Ramos JT; Leal M; Muñoz-Fernández MÁ
    Pediatr Infect Dis J; 2012 Mar; 31(3):273-7. PubMed ID: 22330165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
    Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
    HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection.
    Moore E; Beadsworth MB; Chaponda M; Mhango B; Faragher B; Njala J; Hofland HW; Davies J; Hart IJ; Beeching NJ; Zijlstra EE; van Oosterhout JJ
    J Infect; 2010 Jul; 61(2):155-63. PubMed ID: 20470823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial.
    Meynard JL; Bouteloup V; Landman R; Bonnard P; Baillat V; Cabie A; Kolta S; Izopet J; Taburet AM; Mercie P; Chene G; Girard PM;
    J Antimicrob Chemother; 2010 Nov; 65(11):2436-44. PubMed ID: 20843990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-class HIV antiretroviral therapy failure in an Australian primary care setting.
    Bloch M; Farris M; Tilden D; Gowers A; Cunningham N
    Sex Health; 2010 Mar; 7(1):17-24. PubMed ID: 20152091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan.
    Lai CC; Hung CC; Chen MY; Sun HY; Lu CL; Tseng YT; Chang SF; Su YC; Liu WC; Hsieh CY; Wu PY; Chang SY; Chang SC
    J Antimicrob Chemother; 2012 May; 67(5):1254-60. PubMed ID: 22302562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1-infected patients.
    Zhou HY; Zheng YH; He Y; Chen Z; Liu M; Yin W; Liu C
    Intervirology; 2010; 53(4):240-6. PubMed ID: 20357493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reiter's syndrome as a manifestation of an immune reconstitution syndrome in an HIV-infected patient: successful treatment with doxycycline.
    Neumann S; Kreth F; Schubert S; Mossner J; Caca K
    Clin Infect Dis; 2003 Jun; 36(12):1628-9. PubMed ID: 12802773
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.
    Miró JM; Manzardo C; Pich J; Domingo P; Ferrer E; Arribas JR; Ribera E; Arrizabalaga J; Loncá M; Cruceta A; de Lazzari E; Fuster M; Podzamczer D; Plana M; Gatell JM;
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):747-57. PubMed ID: 20624069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant.
    Feiterna-Sperling C; Hüseman D; Timme J; Bührer C; Obladen M
    Pediatr Infect Dis J; 2008 Jun; 27(6):564-7. PubMed ID: 18449067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete regression of early diffuse B-cell lymphoma in an HIV-positive patient on antiretroviral therapy alone.
    Katsidzira L; Ramsay A; Makunike-Mutasa R; Borok M
    Int J STD AIDS; 2011 Jul; 22(7):409-10. PubMed ID: 21729963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.